Sandoz TV Episode 18: Trailer
Find out what to expect from the newest episode of Sandoz TV.
|Global News||Sandoz Around the World||Sandoz in the Media|
Sandoz’ biosimilar rituximab regulatory submission accepted by European Medicines Agency
Holzkirchen, May 24, 2016
Sandoz, a Novartis division and the global leader in biosimilars, announced today that the European Medicines Agency has accepted their Marketing Authorization Application for a biosimilar to Roche’s EU-licensed MabThera® (rituximab). Rituximab is a monoclonal antibody that is used ...
Ecuador earthquake recovery: Sandoz announces financial support and product donation
Holzkirchen, May 23, 2016
In the wake of the earthquake that devastated northwest Ecuador in April, Sandoz, a Novartis division, today announced that it will support the recovery effort with financial aid and a product donation.
Partnerships towards Universal Health Coverage (UHC)
Holzkirchen, May 20, 2016
A LinkedIn commentary by Harald Nusser, Global Head of Novartis Access.
A decade of progress – and still just beginning
Holzkirchen, May 11, 2016
Carol Lynch, Global Head of Biopharmaceuticals and Chair of the European Biosimilars Group, reflects on a decade of biosimilars.
Sandoz’s Carol Lynch, Global Head Biopharmaceuticals is recognized in a Top 100 list, as the eighth most influential individual in medicine making.
Holzkirchen, April 29, 2016
Sandoz’s Carol Lynch, Global Head Biopharmaceuticals, has been named as one of the most influential people involved in bringing medicines to patients